{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:21:35Z","timestamp":1704846095852},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Bei einer 43-j\u00e4hrigen Patientin mit einem komplikativen Verlauf eines Hirnabszesses konnte im Martin Zeitz Centrum f\u00fcr Seltene Erkrankungen die Diagnose \u201eheredit\u00e4re h\u00e4morrhagische Teleangiektasie\u201c (HHT) gestellt werden. Urs\u00e4chlich f\u00fcr den Hirnabszess zeigten sich HHT-typische pulmonale arterioven\u00f6se Malformationen (AVM). Bei Patient:innen mit kryptogenem Hirnabszess sollte regelhaft ein Screening auf pulmonale AVM und HHT durchgef\u00fchrt werden. Die vorliegende Kasuistik verdeutlicht den hohen Stellenwert der ausf\u00fchrlichen Anamnese sowie die interdisziplin\u00e4re Behandlung bei komplexen Verl\u00e4ufen seltener Erkrankungen.<\/jats:p>","DOI":"10.1007\/s00108-023-01557-3","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T09:02:06Z","timestamp":1688720526000},"page":"71-75","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hirnabszess als Komplikation bei pulmonaler Manifestation einer HHT","Brain abscess as a\u00a0complication of pulmonary manifestation of HHT"],"prefix":"10.1007","volume":"65","author":[{"given":"May Cathleen","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Weiler-Normann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustav","family":"Buescher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"issue":"1","key":"1557_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin\u00a0CL et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91(1):66\u201367","journal-title":"Am J Med Genet"},{"issue":"12","key":"1557_CR2","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s00117-013-2552-z","volume":"53","author":"F Ahlhelm","year":"2013","unstructured":"Ahlhelm\u00a0F et\u00a0al (2013) Morbus Osler [Osler\u2019s disease. Radiologe 53(12):1084\u20131090","journal-title":"Radiologe"},{"issue":"8","key":"1557_CR3","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","volume":"106","author":"H Al-Samkari","year":"2021","unstructured":"Al-Samkari\u00a0H et al (2021) An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica 106(8):2161\u20132169","journal-title":"Haematologica"},{"issue":"1","key":"1557_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13023-019-1281-4","volume":"5","author":"F Robert","year":"2020","unstructured":"Robert\u00a0F et\u00a0al (2020) Future treatments for hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis 5(1):4","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"1557_CR5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","volume":"103","author":"A Kritharis","year":"2018","unstructured":"Kritharis\u00a0A et\u00a0al (2018) Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective. Haematologica 103(9):1433\u20131443","journal-title":"Haematologica"},{"issue":"4","key":"1557_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/cid\/cix373","volume":"65","author":"EJ Boother","year":"2017","unstructured":"Boother\u00a0EJ et al (2017) Cerebral abscess associated with Odontogenic Bacteremias, hypoxemia, and iron loading in Immunocompetent patients with right-to-left shunting through pulmonary Arteriovenous malformations. Clin Infect Dis 65(4):595\u2013603","journal-title":"Clin Infect Dis"},{"key":"1557_CR7","unstructured":"Informationen \u00fcber Zahn\u00e4rztliche Arzneimittel (IZA), Arzneimittelkommission Zahn\u00e4rzte 01\/2022. https:\/\/www.bzaek.de\/fileadmin\/PDFs\/iza_pdf\/IZA.pdf. Zugegriffen: 10.11.2022"},{"issue":"8","key":"1557_CR8","doi-asserted-by":"publisher","first-page":"1093 e1","DOI":"10.1016\/j.cmi.2020.03.011","volume":"26","author":"J Bodilsen","year":"2020","unstructured":"Bodilsen\u00a0J (2020) Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations in brain abscess patients: a\u00a0nationwide, population-based matched cohort study. Clin Microbiol Infect 26(8):1093 e1\u20131093 e3","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1557_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000103205","volume":"74","author":"V Cottin","year":"2007","unstructured":"Cottin\u00a0V et al (2007) Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease). Respiration 74(4):361\u2013378","journal-title":"Respiration"},{"issue":"517","key":"1557_CR10","first-page":"896","volume":"12","author":"FC al at","year":"2016","unstructured":"al at\u00a0FC (2016) Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): clinical manifestations and multidisciplinary management. Rev Med Suisse 12(517):896\u2013901","journal-title":"Rev Med Suisse"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-023-01557-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-023-01557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T14:02:17Z","timestamp":1704808937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-023-01557-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1557"],"URL":"https:\/\/doi.org\/10.1007\/s00108-023-01557-3","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"26 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.C.\u00a0M\u00fcller, C.\u00a0Weiler-Normann, M.\u00a0Meyer, C.\u00a0Schramm und G.\u00a0Buescher geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. <i>Informed Consent:<\/i> Die Patientin hat nach ausf\u00fchrlicher Aufkl\u00e4rung einer anonymen Ver\u00f6ffentlichung und wissenschaftlichen Aufarbeitung ihres Falls (inklusive der Ver\u00f6ffentlichung anonymisierter Bildgebung und Fotografien) zugestimmt. Das unterschriebene Einverst\u00e4ndnis liegt uns schriftlich vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}